Phibro Animal Health

PAHCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.408 B

$34.68 +0.35%

Close of 21 Sept 2026

Revenue

$1.30B

#1380 by revenue

Earnings

$48.3M

#1587 by earnings

Shares outstanding

40,964,000

Latest filing cover page

P/E ratio

29.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#133Ultragenyx PharmaceuticalRARE$1.44B
#134Damora TherapeuticsDMRA$1.41B
#135Phibro Animal HealthPAHC$1.41B
#136Avalyn PharmaAVLN$1.40B
#137Latigo BiotherapeuticsLTGO$1.40B

What if Phibro Animal Health were worth as much as…

Open the what-if tool →

Gold $30.3T

$745,636.92

Per share 21,500× higher

Bitcoin $1.72T

$42,358.02

Per share 1,221× higher

Nvidia $5.48T

$134,966.54

Per share 3,892× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Phibro Animal Health are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.